Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Securities and Exchange Commission v. Mimedx Group, Inc. et al
Case Number:
1:19-cv-10927
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
June 08, 2023
MiMedx Execs To Pay SEC Nearly $2M To End Fraud Claims
Two convicted former executives of skin graft biotechnology company MiMedx have agreed to pay nearly $2 million to the U.S. Securities and Exchange Commission to resolve claims they played a role in orchestrating a "pervasive, long-running fraud" that saw the company strike backroom deals with distributors to misstate millions of dollars of revenue in its public filings.
-
March 28, 2022
Former MiMedx CFO Can't Escape SEC's Fraud Suit
A New York federal judge on Monday denied a bid from the former chief financial officer of MiMedx Group Inc. to dismiss him from a U.S. Securities and Exchange Commission suit over a purported scheme to falsely inflate the biotech company's revenue, finding that the agency sufficiently pled a host of claims.
-
June 22, 2021
Ex-MiMedx CFO Claims Ignorance In Securities Fraud Suit
A former chief financial officer of MiMedx Group Inc. has asked to be excused from a U.S. Securities and Exchange Commission lawsuit targeting him and two former company executives who were convicted in a parallel criminal case, saying he was unaware of a multipronged scheme to falsely inflate the biotech company's revenue by $9.5 million.
-
November 26, 2019
Ex-MiMedx Execs Charged With Cooking Biotech Co.'s Books
Two former top executives of MiMedx Group Inc. on Tuesday were hit with securities fraud charges by New York federal prosecutors over a purported multi-pronged scheme to falsely inflate the biotech company's revenue.